Witasp A - Search Results

1

Inflammation and Premature Ageing in Chronic Kidney Disease.

Ebert T, Pawelzik SC, Witasp A, Arefin S, Hobson S, Kublickiene K, Shiels PG, Bäck M, Stenvinkel P. Ebert T, et al. Among authors: witasp a. Toxins (Basel). 2020 Apr 4;12(4):227. doi: 10.3390/toxins12040227. Toxins (Basel). 2020. PMID: 32260373 Free PMC article. Review.

2

Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.

Axelsson J, Møller HJ, Witasp A, Qureshi AR, Carrero JJ, Heimbürger O, Bárány P, Alvestrand A, Lindholm B, Moestrup SK, Stenvinkel P. Axelsson J, et al. Among authors: witasp a. Am J Kidney Dis. 2006 Dec;48(6):916-25. doi: 10.1053/j.ajkd.2006.08.022. Am J Kidney Dis. 2006. PMID: 17162146

3

Use of single-nucleotide polymorphisms in the search for genetic modifiers of the uremic phenotype.

Witasp A, Nordfors L, Lindholm B, Stenvinkel P. Witasp A, et al. J Ren Nutr. 2007 Jan;17(1):17-22. doi: 10.1053/j.jrn.2006.10.005. J Ren Nutr. 2007. PMID: 17198927 Review.

4

Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.

Axelsson J, Witasp A, Carrero JJ, Qureshi AR, Suliman ME, Heimbürger O, Bárány P, Lindholm B, Alvestrand A, Schalling M, Nordfors L, Stenvinkel P. Axelsson J, et al. Among authors: witasp a. Am J Kidney Dis. 2007 Feb;49(2):237-44. doi: 10.1053/j.ajkd.2006.11.021. Am J Kidney Dis. 2007. PMID: 17261426

5

Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels.

Carrero JJ, Witasp A, Stenvinkel P, Qureshi AR, Heimbürger O, Bárány P, Suliman ME, Anderstam B, Lindholm B, Nordfors L, Schalling M, Axelsson J. Carrero JJ, et al. Among authors: witasp a. Nephrol Dial Transplant. 2010 Mar;25(3):901-6. doi: 10.1093/ndt/gfp587. Epub 2009 Nov 30. Nephrol Dial Transplant. 2010. PMID: 19948877

6

Increased expression of pro-inflammatory genes in abdominal subcutaneous fat in advanced chronic kidney disease patients.

Witasp A, Carrero JJ, Heimbürger O, Lindholm B, Hammarqvist F, Stenvinkel P, Nordfors L. Witasp A, et al. J Intern Med. 2011 Apr;269(4):410-9. doi: 10.1111/j.1365-2796.2010.02293.x. Epub 2010 Nov 5. J Intern Med. 2011. PMID: 21054584 Free article.

7

Expression of osteoprotegerin in human fat tissue; implications for chronic kidney disease.

Witasp A, Carrero JJ, Hammarqvist F, Qureshi AR, Heimbürger O, Schalling M, Lindholm B, Nordfors L, Stenvinkel P. Witasp A, et al. Eur J Clin Invest. 2011 May;41(5):498-506. doi: 10.1111/j.1365-2362.2010.02432.x. Epub 2010 Dec 3. Eur J Clin Invest. 2011. PMID: 21128937

8

Genetic studies in chronic kidney disease: basic concepts.

Nordfors L, Luttropp K, Carrero JJ, Witasp A, Stenvinkel P, Lindholm B, Schalling M. Nordfors L, et al. Among authors: witasp a. J Nephrol. 2012 Mar-Apr;25(2):141-9. doi: 10.5301/jn.5000145. J Nephrol. 2012. PMID: 22437428 Review.

9

Genetic studies in chronic kidney disease: interpretation and clinical applicability.

Witasp A, Nordfors L, Carrero JJ, Luttropp K, Lindholm B, Schalling M, Stenvinkel P. Witasp A, et al. J Nephrol. 2012 Nov-Dec;25(6):851-64. doi: 10.5301/jn.5000216. J Nephrol. 2012. PMID: 23042432 Review.

10

Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.

Witasp A, Rydén M, Carrero JJ, Qureshi AR, Nordfors L, Näslund E, Hammarqvist F, Arefin S, Kublickiene K, Stenvinkel P. Witasp A, et al. PLoS One. 2013 May 3;8(5):e63493. doi: 10.1371/journal.pone.0063493. Print 2013. PLoS One. 2013. PMID: 23658833 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page